Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of… May 18, 2021
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip May 17, 2021
COMPASS Pathways plc announces financial results and business highlights for the Q1 2021 May 13, 2021
Psybio Therapeutics CEO Evan Levine: “Our Method Synthesizes Psilocybin Cheaper, Faster, And Greener” Than The Others May 13, 2021
PsyBio Therapeutics Increases Intellectual Property Portfolio with Filing of Novel Genetic Optimization Pathways for… May 12, 2021
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial… May 11, 2021
